Is it safe to readminister tumor necrosis factor alpha antagonists following tuberculosis flare?

Arthritis Rheum. 2008 Jan;58(1):327-8. doi: 10.1002/art.23210.
No abstract available

MeSH terms

  • Adalimumab
  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Recurrence
  • Tuberculosis, Pulmonary / complications*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab